These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 19829687)
1. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter]. Pan YX; Wu Y; Niu ZP; Jiang YW Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687 [TBL] [Abstract][Full Text] [Related]
2. Leukoencephalopathy with vanishing white matter: a review. Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246 [TBL] [Abstract][Full Text] [Related]
3. eIF2B: recent structural and functional insights into a key regulator of translation. Wortham NC; Proud CG Biochem Soc Trans; 2015 Dec; 43(6):1234-40. PubMed ID: 26614666 [TBL] [Abstract][Full Text] [Related]
4. Vanishing white matter: deregulated integrated stress response as therapy target. Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619 [TBL] [Abstract][Full Text] [Related]
5. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386 [TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum stress intolerance in EIF2B3 mutant oligodendrocytes is modulated by depressed autophagy. Chen N; Dai L; Jiang Y; Wang J; Hao H; Ren Y; Leng X; Zang L; Wu Y Brain Dev; 2016 May; 38(5):507-15. PubMed ID: 26625702 [TBL] [Abstract][Full Text] [Related]
7. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model. Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290 [TBL] [Abstract][Full Text] [Related]
8. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758 [TBL] [Abstract][Full Text] [Related]
9. Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells. Sekine Y; Zyryanova A; Crespillo-Casado A; Amin-Wetzel N; Harding HP; Ron D PLoS One; 2016; 11(11):e0166278. PubMed ID: 27812215 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease. Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247 [TBL] [Abstract][Full Text] [Related]
11. Human-induced pluripotent stem cell-derived cerebral organoid of leukoencephalopathy with vanishing white matter. Deng J; Zhang J; Gao K; Zhou L; Jiang Y; Wang J; Wu Y CNS Neurosci Ther; 2023 Apr; 29(4):1049-1066. PubMed ID: 36650674 [TBL] [Abstract][Full Text] [Related]
13. A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease. de Almeida RA; Fogli A; Gaillard M; Scheper GC; Boesflug-Tanguy O; Pavitt GD PLoS One; 2013; 8(1):e53958. PubMed ID: 23335982 [TBL] [Abstract][Full Text] [Related]
14. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy. Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085 [TBL] [Abstract][Full Text] [Related]
15. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease. Wortham NC; Proud CG BMC Med Genet; 2015 Aug; 16():64. PubMed ID: 26285592 [TBL] [Abstract][Full Text] [Related]
17. Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease. Raini G; Sharet R; Herrero M; Atzmon A; Shenoy A; Geiger T; Elroy-Stein O J Neurochem; 2017 Jun; 141(5):694-707. PubMed ID: 28306143 [TBL] [Abstract][Full Text] [Related]
18. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease]. Kashiwagi K; Ito T; Yokoyama S Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977 [TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the alpha subunit of eIF2B provides insights into the role of eIF2B bodies in translational control and VWM disease. Norris K; Hodgson RE; Dornelles T; Allen KE; Abell BM; Ashe MP; Campbell SG J Biol Chem; 2021; 296():100207. PubMed ID: 33334879 [TBL] [Abstract][Full Text] [Related]
20. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Li W; Wang X; Van Der Knaap MS; Proud CG Mol Cell Biol; 2004 Apr; 24(8):3295-306. PubMed ID: 15060152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]